ROYCE & ASSOCIATES LP - BALCHEM CORP ownership

BALCHEM CORP's ticker is BCPC and the CUSIP is 057665200. A total of 257 filers reported holding BALCHEM CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of BALCHEM CORP
ValueSharesWeighting
Q3 2023$8,477,638
-8.0%
68,3460.0%0.09%
-3.4%
Q2 2023$9,213,724
+6.6%
68,3460.0%0.09%
+2.3%
Q1 2023$8,644,402
+3.6%
68,3460.0%0.09%
-1.1%
Q4 2022$8,345,730
+0.4%
68,3460.0%0.09%
-6.4%
Q3 2022$8,310,000
-6.3%
68,3460.0%0.09%
+3.3%
Q2 2022$8,867,000
-5.1%
68,3460.0%0.09%
+15.2%
Q1 2022$9,343,000
-18.9%
68,3460.0%0.08%
-8.1%
Q4 2021$11,523,000
+13.8%
68,346
-2.1%
0.09%
+13.2%
Q3 2021$10,125,000
+7.5%
69,792
-2.8%
0.08%
+16.9%
Q2 2021$9,421,000
-0.5%
71,772
-4.9%
0.06%
+1.6%
Q1 2021$9,465,000
-33.0%
75,472
-38.4%
0.06%
-45.3%
Q4 2020$14,123,000
+15.0%
122,572
-2.6%
0.12%
-12.0%
Q3 2020$12,284,000
+2.9%
125,8220.0%0.13%
+1.5%
Q2 2020$11,935,000
-48.9%
125,822
-46.8%
0.13%
-58.8%
Q1 2020$23,352,000
-7.2%
236,549
-4.4%
0.32%
+41.3%
Q4 2019$25,158,000
-3.2%
247,549
-5.6%
0.22%
-6.6%
Q3 2019$26,000,000
-3.0%
262,121
-2.2%
0.24%
-0.4%
Q2 2019$26,794,000
+6.2%
268,021
-1.4%
0.24%
+13.6%
Q1 2019$25,225,000
+15.2%
271,821
-2.7%
0.21%
+8.7%
Q4 2018$21,896,000
-32.4%
279,468
-3.3%
0.20%
-12.5%
Q3 2018$32,409,000
+14.2%
289,1360.0%0.22%
+14.3%
Q2 2018$28,376,000
+13.7%
289,136
-5.3%
0.20%
+12.0%
Q1 2018$24,962,000
-37.1%
305,344
-38.0%
0.18%
-33.7%
Q4 2017$39,666,000
-12.6%
492,136
-11.9%
0.26%
-12.3%
Q3 2017$45,385,000
-4.6%
558,312
-8.8%
0.30%
-4.7%
Q2 2017$47,595,000
-22.6%
612,468
-17.9%
0.32%
-21.4%
Q1 2017$61,458,000
-15.6%
745,668
-14.1%
0.40%
-13.9%
Q4 2016$72,845,000
+2.1%
868,024
-5.7%
0.47%
-0.6%
Q3 2016$71,360,000
+30.0%
920,4240.0%0.47%
+29.5%
Q2 2016$54,903,000
-6.1%
920,424
-2.3%
0.36%
-1.6%
Q1 2016$58,455,000
-5.2%
942,524
-7.1%
0.37%
+0.3%
Q4 2015$61,686,000
-6.0%
1,014,574
-6.0%
0.37%
+5.7%
Q3 2015$65,594,000
+9.7%
1,079,374
+0.5%
0.35%
+37.5%
Q2 2015$59,820,000
-8.8%
1,073,574
-9.4%
0.25%
+2.0%
Q1 2015$65,591,000
-24.5%
1,184,374
-9.2%
0.25%
-17.9%
Q4 2014$86,923,000
+3.3%
1,304,374
-12.3%
0.30%
+6.3%
Q3 2014$84,163,000
+5.2%
1,487,774
-0.4%
0.28%
+19.3%
Q2 2014$79,980,000
+2.3%
1,493,274
-0.5%
0.24%
+3.0%
Q1 2014$78,220,000
-11.2%
1,500,7740.0%0.23%
-8.3%
Q4 2013$88,095,000
+15.8%
1,500,774
+2.1%
0.25%
+11.5%
Q3 2013$76,082,000
+15.6%
1,470,1740.0%0.23%
+11.3%
Q2 2013$65,790,0001,470,1740.20%
Other shareholders
BALCHEM CORP shareholders Q4 2020
NameSharesValueWeighting ↓
SANTA MONICA PARTNERS LP 353,431$59,588,00037.96%
Conestoga Capital Advisors, LLC 1,000,708$168,719,0002.20%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 71,969$12,134,0001.86%
Tributary Capital Management, LLC 140,224$23,642,0001.78%
GENEVA CAPITAL MANAGEMENT LLC 651,326$109,813,0001.77%
Cutter & CO Brokerage, Inc. 33,549$5,656,0001.55%
WASATCH ADVISORS LP 1,693,842$285,582,0001.16%
MOODY ALDRICH PARTNERS LLC 49,518$8,349,0001.16%
ICW Investment Advisors LLC 10,875$1,834,0001.02%
Kensington Investment Counsel, LLC 9,074$1,530,0000.89%
View complete list of BALCHEM CORP shareholders